Related Experiment Video
Updated: Jun 26, 2025
06:11
Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
Published on: April 20, 2018
9.8K
Efficiency of moderately hypofractionated radiotherapy in NSCLC cell model
Marcus Lüdeking1, Katharina Stemwedel1, Dhanya Ramachandran1,2
1Radiation Oncology Research Unit, Hannover Medical School, Hannover, Germany.
Frontiers in Oncology
|May 9, 2024
Summary
Moderate hypofractionation radiotherapy shows similar effectiveness and toxicity compared to standard treatment for non-small cell lung cancer (NSCLC). This approach may improve patient survival and outcomes in clinical practice.
Area of Science:
- Oncology
- Radiation Oncology
- Cancer Biology
Background:
- Standard radiotherapy for locally advanced NSCLC uses 2.0 Gy fractions, yielding suboptimal outcomes.
- Hypofractionated radiotherapy, particularly moderate hypofractionation, offers shorter treatment duration and greater patient convenience.
- Controversial clinical trial results necessitate further pre-clinical radiobiological investigation of moderate hypofractionation.
Purpose of the Study:
- To comparatively analyze the radiobiological effectiveness of moderate hypofractionation versus normofractionation in NSCLC.
- To evaluate cell proliferation, DNA repair, and survival across different NSCLC cell lines and fibroblasts under varied radiation schedules.
Main Methods:
- Irradiation of four NSCLC cell lines and fibroblasts with 24x2.75 Gy (moderate hypofractionation) or 30x2 Gy (normofractionation).
- Assessment of cell proliferation (cell counting, MTT, EdU assay) and DNA repair (γH2AX/53BP1 foci).
- Evaluation of cell survival using clonogenic assay (CSA).
Main Results:
- Significant differences in cell sensitivity and response to both radiation schedules were observed, highlighting cell-specific effects.
- Moderate hypofractionation demonstrated a stronger effect on cell proliferation and survival compared to normofractionation across all tested cell lines.
- Statistical analysis (P < 0.0001) confirmed significant differences between the schedules for all cell lines and assays.
Conclusions:
- Both moderate hypofractionation and normofractionation exhibit comparable effectiveness and toxicity in NSCLC models.
- Preliminary findings suggest a potential advantage for moderate hypofractionation, indicating that higher doses per fraction may enhance patient survival and therapeutic results.
